Impact of aging on the incidence and mortality of urological cancers: 20-year projection in Spain

Autores de IIS La Fe

• Francisco Gómez Palomo

  Autor

• Jose Vicente Sanchez Gonzalez

  Autor

• Adrián Bernal Gómez

  Autor

• Javier Pérez Ardavín

  Autor

• José Luis Ruiz Cerdá

  Autor

Grupos

• Núcleo de investigación traslacional integrado Urológico de Valencia (NITIUV)

  

  Leader

  César David Vera Donoso

• Unidad Mixta de Investigación en Nanomedicina y Sensores

  Leader

  Ramón Martínez Máñez

Abstract

Introduction: In 2020, 282,421 new cases of cancer were diagnosed in Spain, and urological neoplasms (UN) were among the most frequent ones. Cancer treatment in elderly people is challenging due to frailty and comorbidities. Healthcare resources must be optimized in order to meet the needs of treating UN in the elderly, and deep analysis of cancer registries becomes mandatory. The objective of this work was to provide a detailed analysis of the incidence and mortality of UN in patients over 65 years old in the last year 2020 in Spain, as well as the estimates for the year 2040. Material and methods: Incidence and mortality estimates were obtained from the GLOBOCAN database. The UN included were testicle, bladder, penis, kidney, and prostate. Results: In 2020, 63,278 cases of UN were diagnosed in Spain. Most UN were much more frequent among patients > 65 years old, except for testicular cancers. For the year 2040, an increased incidence of 41.5% is estimated, reaching 89,507 new cases of UN per year, with approximately 3 out of 4 patients over 65 years of age. Deaths in people over 65 will increase by 60.15% in 2040. Conclusion: In the next two decades, it is expected that new cases of UN in people over 65 years will rise above 50%. More financial and human resources, as welt as multidisciplinary teams with experience and geriatric training, will be necessary. (C)2021 AEU. Published by Elsevier Espana, S.L.U. All rights reserved.

Keywords

• Cancer; Geriatrics; Incidence; Mortality; Trend